Zydus Pharms` Generic Vortioxetine Hydrobromide Receives Tentative Approval in the U.S.
Prinston's Generic Vortioxetine Receives Tentative Approval in the U.S.
Alembic Pharmaceuticals Ltd on Friday said it has received tentative approval from the US health regulator for its generic Vortioxetine tablets indicated for the treatment of the major depressive disorder.
Alembic Pharm's Generic Vortioxetine Receives Approval in the U.S.
In a new real-world study, the ability of Trintellix/Brintellix® (vortioxetine) to improve functioning in family, social, and work life for people living with Major Depressive Disorder was assessed. The trial included 994 patients and shows a significant improvement in overall functioning after three months and sustained and further improved over a six-month period.
Amneal Pharm`s Generic Vortioxetine Receives Tentative Approval In US
Alkem Labs Generic Vortioxetine Receives Tentative Approval in US
Rising demand for Lundbeck’s four key products enabled the company to narrowly beat analyst sales expectations in the second quarter.
New Delhi: 11th October 2018: Lundbeck India Private Limited (LIPL) announces the launch of Brintellix® (Vortioxetine) in India for the treatment of patients suffering from Major Depressive Disorder (MDD) after receiving approval from Drug Controller General of India (DCGI).
New Delhi: 11th October 2018: Lundbeck India Private Limited (LIPL) announces the launch of Brintellix® (Vortioxetine) in India for the treatment of patients suffering from Major Depressive Disorder (MDD) after receiving approval from Drug Controller General of India (DCGI).